黄芪三萜皂苷通过抑制TLR-4/NF-κB p65信号调节的炎症反应而发挥保护病毒性心肌炎的作用研究

被引:11
作者
杨怡侠 [1 ]
刘天龙 [2 ]
刘晶 [2 ]
张勇 [1 ]
杨秀华 [3 ]
肖云峰 [3 ]
刘小雷 [3 ]
机构
[1] 呼和浩特市蒙医中医医院药剂科
[2] 内蒙古医科大学附属医院药剂科
[3] 内蒙古医科大学药理学教研室
关键词
黄芪三萜皂苷; 病毒性心肌炎; 炎症; TLR-4/NF-κB p65信号;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
目的研究黄芪三萜皂苷(AST)对病毒性心肌炎的治疗作用及机制。方法利用CVB3病毒和BALB/c小鼠制备病毒性心肌炎模型,并使用AST进行干预。记录各组生存曲线,行心肌组织HE染色,检测血浆中心肌肌钙蛋白T(c Tn T)水平及心肌组织中ANP、BNP、IL-1β、IL-6、TNF-α及INF-γ表达水平以评价心肌的炎症水平,检测心肌组织中TLR-4、Phospho-p65-NF-κB表达和活化水平以探讨AST抗CVB3诱导炎症的机制。结果 AST能够显著提高小鼠的生存率,减少小鼠CVB3诱导的心肌损伤面积,降低血液中c Tn T水平,抑制CVB3诱导的ANP和BNP在心肌组织中表达。AST对CVB3诱导小鼠心肌组织中IL-1β、IL-6、TNF-α及INF-γ表达水平增加有显著的抑制作用。CVB3诱导组小鼠心肌组织中TLR-4表达水平显著增加,磷酸化NF-κB p65表达和活性均显著增加,而AST对CVB3诱导的TLR-4/NF-κB p65信号的活化具有显著抑制作用。结论 AST对CVB3诱导的病毒性心肌炎具有显著的治疗作用,主要是通过抑制CVB3诱导的TLR-4/NF-κB p65信号活化,减弱心肌组织的炎症反应实现的。
引用
收藏
页码:1705 / 1709
页数:5
相关论文
共 13 条
[1]   Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway [J].
Zhou, Ruijuan ;
Chen, Hongjiu ;
Chen, Junpeng ;
Chen, Xuemei ;
Wen, Yu ;
Xu, Leqin .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
[2]   A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis [J].
Rienks, Marieke ;
Papageorgiou, Anna ;
Wouters, Kristiaan ;
Verhesen, Wouter ;
van Leeuwen, Rick ;
Carai, Paolo ;
Summer, Georg ;
Westermann, Dirk ;
Heymans, Stephane .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (08) :1511-1525
[3]  
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation[J] . Yuping Zhou,Xin Tong,Shuang Ren,Xiaoling Wang,Jiamei Chen,Yongping Mu,Mingyu Sun,Gaofeng Chen,Hua Zhang,Ping Liu.Journal of Ethnopharmacology . 2016
[4]  
Effects of Astragalus Polysaccharides on Dysfunction of Mitochondrial Dynamics Induced by Oxidative Stress[J] . Yan-Feng Huang,Lu Lu,Da-Jian Zhu,Ming Wang,Yi Yin,De-Xiu Chen,Lian-Bo Wei,Ryuichi Morishita.Oxidative Medicine and Cellular Longevity . 2016
[5]  
Inflammation in viral myocarditis: friend or foe?[J] . Maarten F. Corsten,Blanche Schroen,Stephane Heymans.Trends in Molecular Medicine . 2012 (7)
[6]   α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis [J].
Wu, C. Y. ;
Feng, Y. ;
Qian, G. C. ;
Wu, J. H. ;
Luo, J. ;
Wang, Y. ;
Chen, G. J. ;
Guo, X. K. ;
Wang, Z. J. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (01) :178-187
[7]  
Alternative Activation of Macrophages: Mechanism and Functions[J] . Siamon Gordon,Fernando O. Martinez.Immunity . 2010 (5)
[8]   REMISSION OF MEMBRANOUS NEPHROPATHY AFTER THERAPY WITH ASTRAGALUS MEMBRANACEUS [J].
Leehey, David J. ;
Casini, Tony ;
Massey, Donald .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) :772-772
[9]  
Molecular Biology and Pathogenesis of Viral Myocarditis[J] . Mitra Esfandiarei,Bruce M. McManus.Annual Review of Pathology: Mechanisms of Disease . 2008
[10]  
Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production[J] . Koichi Fuse,Grace Chan,Youan Liu,Patrick Gudgeon,Mansoor Husain,Manyin Chen,Wen-Chen Yeh,Shizuo Akira,Peter P. Liu.Circulation . 2005 (15)